טוען...
Bivalirudin Use in an Infant With Persistent Clotting on Unfractionated Heparin
Bivalirudin is a direct thrombin inhibitor approved for use in adult patients with heparin-induced thrombocytopenia (HIT) undergoing percutaneous coronary intervention. Recently, its use in the pediatric population has increased due to its anti-thrombin-independent mechanism of action. As heparin pr...
שמור ב:
| Main Authors: | , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Pediatric Pharmacy Advocacy Group
2011
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3208438/ https://ncbi.nlm.nih.gov/pubmed/22477834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5863/1551-6776-16.2.108 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|